Compare OLMA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLMA | BVS |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 949.3M | 910.2M |
| IPO Year | 2020 | 2016 |
| Metric | OLMA | BVS |
|---|---|---|
| Price | $7.20 | $10.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $35.50 | $16.60 |
| AVG Volume (30 Days) | ★ 1.4M | 613.2K |
| Earning Date | 11-10-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.00 | ★ 163.46 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $4.72 |
| Revenue Next Year | N/A | $6.41 |
| P/E Ratio | ★ N/A | $17.68 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.24 | $6.47 |
| 52 Week High | $36.26 | $15.89 |
| Indicator | OLMA | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 34.26 |
| Support Level | $6.47 | $8.21 |
| Resistance Level | $7.61 | $11.00 |
| Average True Range (ATR) | 0.59 | 0.67 |
| MACD | 0.07 | -0.13 |
| Stochastic Oscillator | 30.43 | 12.37 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.